These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20409316)

  • 21. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
    Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
    Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer.
    Jung SH; Lee A; Yim SH; Hu HJ; Choe C; Chung YJ
    BMC Cancer; 2012 Aug; 12():382. PubMed ID: 22938721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of genomic instability in breast cancer in atomic bomb survivors: analysis of microarray-comparative genomic hybridization.
    Oikawa M; Yoshiura K; Kondo H; Miura S; Nagayasu T; Nakashima M
    Radiat Oncol; 2011 Dec; 6():168. PubMed ID: 22152285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copy number alterations associated with clinical features in an underrepresented population with breast cancer.
    Rodrigues-Peres RM; de S Carvalho B; Anurag M; Lei JT; Conz L; Gonçalves R; Cardoso Filho C; Ramalho S; de Paiva GR; Derchain SFM; Lopes-Cendes I; Ellis MJ; Sarian LO
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00750. PubMed ID: 31099189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q.
    Riener MO; Nikolopoulos E; Herr A; Wild PJ; Hausmann M; Wiech T; Orlowska-Volk M; Lassmann S; Walch A; Werner M
    Hum Pathol; 2008 Nov; 39(11):1621-9. PubMed ID: 18656243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
    Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ
    Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression Potential of Ductal Carcinoma in situ Assessed by Genomic Copy Number Profiling.
    Kitamura M; Nakayama T; Mukaisho KI; Mori T; Umeda T; Moritani S; Kushima R; Tani M; Sugihara H
    Pathobiology; 2019; 86(2-3):92-101. PubMed ID: 30332671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis.
    Rane SU; Mirza H; Grigoriadis A; Pinder SE
    Breast Cancer Res Treat; 2015 Aug; 153(1):101-21. PubMed ID: 26255059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S; Wei B; Zhang H; Qing M; Bu H
    Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.
    Aubele M; Cummings M; Walsch A; Zitzelsberger H; Nährig J; Höfler H; Werner M
    Anal Cell Pathol; 2000; 20(1):17-24. PubMed ID: 11007434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization.
    Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Hutzler P; Höfler H; Werner M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):94-102. PubMed ID: 10214356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer.
    Aubele MM; Cummings MC; Mattis AE; Zitzelsberger HF; Walch AK; Kremer M; Höfler H; Werner M
    Diagn Mol Pathol; 2000 Mar; 9(1):14-9. PubMed ID: 10718208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy.
    Litviakov NV; Cherdyntseva NV; Tsyganov MM; Slonimskaya EM; Ibragimova MK; Kazantseva PV; Kzhyshkowska J; Choinzonov EL
    Oncotarget; 2016 Feb; 7(7):7829-41. PubMed ID: 26799285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues.
    Tsuji K; Kawauchi S; Saito S; Furuya T; Ikemoto K; Nakao M; Yamamoto S; Oka M; Hirano T; Sasaki K
    BMC Cancer; 2010 Jan; 10():15. PubMed ID: 20070913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
    Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
    Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.